Jones J - Search Results

1

Effect of procurement-related organ lesions on renal transplant outcome.

Bentas W, Jones J, Urbschat A, Tilp U, Probst M, Scheuermann E, Hauser IA, Blaheta RA, Jonas D, Gossmann J. Bentas W, et al. Among authors: jones j. Clin Transplant. 2008 Jul-Aug;22(4):411-7. doi: 10.1111/j.1399-0012.2008.00799.x. Epub 2008 Feb 3. Clin Transplant. 2008. PMID: 18261118

2

Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme.

Bentas W, Jones J, Karaoguz A, Tilp U, Probst M, Scheuermann E, Hauser IA, Jonas D, Gossmann J. Bentas W, et al. Among authors: jones j. Nephrol Dial Transplant. 2008 Jun;23(6):2043-51. doi: 10.1093/ndt/gfm912. Epub 2008 Jan 18. Nephrol Dial Transplant. 2008. PMID: 18203840

3

[Quality of kidney procurement in Germany. Ten years experience and 486 renal allografts in a single centre].

Bentas W, Probst M, Jones J, Karaoguz A, Cerovac I, Scheuermann E, Hauser IA, Jonas D, Gossmann J. Bentas W, et al. Among authors: jones j. Urologe A. 2007 Mar;46(3):268-70, 271-3. doi: 10.1007/s00120-006-1279-0. Urologe A. 2007. PMID: 17268756 German.

4

Postoperative voiding dysfunction in older male renal transplant recipients.

Tsaur I, Jones J, Melamed RJ, Blaheta RA, Gossmann J, Bentas W. Tsaur I, et al. Among authors: jones j. Transplant Proc. 2009 Jun;41(5):1615-8. doi: 10.1016/j.transproceed.2009.01.110. Transplant Proc. 2009. PMID: 19545691

5

Saphenous vein interposition as a salvage technique for complex vascular situations during renal transplantation.

Oertl AJ, Jonas D, Oremek GM, Jones J. Oertl AJ, et al. Among authors: jones j. Transplant Proc. 2007 Jan-Feb;39(1):140-2. doi: 10.1016/j.transproceed.2006.10.205. Transplant Proc. 2007. PMID: 17275492

6

The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo.

Jones J, Juengel E, Mickuckyte A, Hudak L, Wedel S, Jonas D, Blaheta RA. Jones J, et al. J Cell Mol Med. 2009 Aug;13(8B):2376-2385. doi: 10.1111/j.1582-4934.2008.00436.x. Epub 2008 Jul 24. J Cell Mol Med. 2009. PMID: 18657224 Free PMC article.

7

Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.

Jones J, Bentas W, Blaheta RA, Makarevic J, Hudak L, Wedel S, Probst M, Jonas D, Juengel E. Jones J, et al. Int J Mol Med. 2008 Sep;22(3):293-9. Int J Mol Med. 2008. PMID: 18698487

8

Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrix.

Jones J, Juengel E, Mickuckyte A, Hudak L, Wedel S, Jonas D, Hintereder G, Blaheta RA. Jones J, et al. J Cell Mol Med. 2009 Aug;13(8B):2342-2352. doi: 10.1111/j.1582-4934.2008.00603.x. J Cell Mol Med. 2009. PMID: 19067765 Free PMC article.

9

Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells.

Juengel E, Engler J, Natsheh I, Jones J, Mickuckyte A, Hudak L, Jonas D, Blaheta RA. Juengel E, et al. Among authors: jones j. BMC Cancer. 2009 May 27;9:161. doi: 10.1186/1471-2407-9-161. BMC Cancer. 2009. PMID: 19473483 Free PMC article.

10

Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro.

Juengel E, Engler J, Mickuckyte A, Jones J, Hudak L, Jonas D, Blaheta RA. Juengel E, et al. Among authors: jones j. BJU Int. 2010 Feb;105(4):549-57. doi: 10.1111/j.1464-410X.2009.08759.x. Epub 2009 Jul 7. BJU Int. 2010. PMID: 19594733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,717 results

Search Page

Filters